Chase AIPricingFAQs
Display currency
Loading news…

Onkaido Therapeutics

ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).
Cambridge, Massachusetts, United States Founded 2013 11-50 employees For Profit

The Onkaido Therapeutics team is exploring how messenger RNA therapeutics™ can deliver novel oncology drugs to help patients.

Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
0

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
5
Active products
2
IT spend
$9M

Company Info

Founded
2013
Employees
11-50
Operating status
Closed
Company type
For Profit
Org types
company
Founders
1
HQ
Cambridge, Massachusetts, United States
Region
Greater Boston Area, East Coast, New England
Closed
Dec 29, 2017

Signals & Scores

Heat score
Low
Trend (7d)
-0.3
Trend (30d)
-2.5
Trend (90d)
-0.7

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to Onkaido Therapeutics

Loading news…

FAQs about Onkaido Therapeutics

People who checked this page also checked these

Browse the full Acquirezy directory.
Onkaido Therapeutics - Company Profile, Full Acquisitions List, Funding and Investments